COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia

BACKGROUND: Studies of mRNA and vector-based vaccines used in different countries report acceptable levels of effectiveness against SARS-CoV-2 infection caused by the Delta variants of SARS-CoV-2. No studies estimated vaccine effectiveness (VE) of Gam-COVID-Vac and other vaccines used in Russia agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Barchuk, Anton, Bulina, Anna, Cherkashin, Mikhail, Berezina, Natalia, Rakova, Tatyana, Kuplevatskaya, Darya, Stanevich, Oksana, Skougarevskiy, Dmitriy, Okhotin, Artemiy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503256/
https://www.ncbi.nlm.nih.gov/pubmed/36138385
http://dx.doi.org/10.1186/s12889-022-14202-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503256/
https://www.ncbi.nlm.nih.gov/pubmed/36138385
http://dx.doi.org/10.1186/s12889-022-14202-9

Ejemplares similares